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AKTIVITI ANTIMIKROB, ANTIKANSER DAN ANTIOKSIDAN EKSTRAK 
METANOL DARI DAUN Elaeis guineensis Jacq 
 
ABSTRAK 
 
Malaysia merupakan sebuah negara penghasil minyak kelapa sawit berskala industri, 
juga pernah diberi pengiktirafan berperingat antarabangsa berasaskan kesungguhan 
dalam penghasilannya yang memuncak. Meskipun perladangan kelapa sawit 
menyumbang banyak ke negara, tetapi sisa buangan yang diperoleh daripada 
penanaman semula, penuaian dan pengeringan telah mancetus jalan ke pelbagai 
masalah. Hasil sampingan berkepelbagaian kelapa sawit dan daun kelapa sawit, 
dilaporkan menyumbang 70% kepada keseluruhan sisa industri kelapa sawit negara 
dengan mencapai 30 juta tan biomas setahun termasuk batang, daun dan tandan buah. 
Salah satu punca masalahnya yang ketara boleh dilihat dalam aspek pengurusan hasil 
sisa buangan sampingan semasa pemprosesan buah kelapa sawit. Maka dari itu, 
kajian ini telah dijalankan demi mengubah hasil buangan industri ke bahan bernilai 
industri farmaseutikal dengan mengambil kira penilaian aktiviti antimikrob, 
antikanser, antioksidan dan sitotoksik.  Aktiviti antimikrob telah dikaji melalui 
kaedah peresapan disk dan kaedah pencairan kaldu. Ekstrak didapati berkesan 
terhadap mikroorganisma ujian dan nilai kepekatan perencatan minimum (MIC) 
didapati dalam julat 6.25- 50.00 mg/mL. Ekstrak daun E. guineensis menunjukkan 
aktiviti yang amat baik terhadap kulat patogen C. albicans dengan mencapai nilai 
MIC 6.25 mg/mL dan keputusan ini disahkan melalui kajian asai bunuh mengikut 
masa. Kajian mikroskopi elektron pengimbasan (SEM) dan transmisi (TEM) telah 
diamalkan untuk memerhati dan membezakan metamorfosis morfologi C. albicans 
yang diolah ekstrak dengan kawalannya tanpa olahan. Keputusan SEM dan TEM 
menunjukkan kesan yang signifikasi terhadap dinding sel dan kandungan sitoplasma 
xix 
 
sel C. albicans yang kemudiannya diperhatikan musnah apabila didedah pada ekstrak 
daun E. guineensis berkepekatan 6.25 mg/mL selama 36 jam. Kajian aktiviti 
antikanser pula telah dijalankan dengan menggunakan sel kanser MCF-7 dan sel 
bukan kanser Vero melalui kaedah ujian MTT.  Ekstrak didapati merencatkan sel 
kanser MCF-7 dengan nilai perencatan 50% (IC50) iaitu 15.26 μg/ml dan sel Vero 
dengan nilai 22.53 μg/ml (IC50). Secara kesimpulannya, keputusan kajian antikanser 
menunjukkan ekstrak bertindak sebagai agen antikanser terhadap sel MCF-7. Selain 
daripada kajian antimikrob dan antikanser, kajian antioksidan dengan menggunakan 
kaedah penjerapan radikal difenil-1-pikrilhidrazil (DPPH), kandungan jumlah fenol, 
asai perencatan xantin oksidase (XOI), asai perencatan nitrik oksida (NOI), asai 
perencatan hidrogen peroksida (HPSA) juga telah dijalankan. Ekstrak daun E. 
guineensis didapati mempamerkan aktiviti perencatan DPPH, XOI, NOI dan HPSA 
dengan nilai IC50 sebanyak 814.00 μg/mL, 37.48 g/mL, 534.04 g/mL dan 1052.02 
g/mL masing-masing manakala jumlah kandungan fenol dicatatkan sebanyak 333.3 
µg GAE/g ekstrak kering. Kajian sitotoksik ekstrak daun E. guineensis telah 
dilakukan dengan menggunakan kaedah kematian anak udang brin (Artemia salina) 
dan kaedah ketoksikan oral akut yang dijalankan ke atas mencit albino Swiss, dimana 
kajian mencit diakhiri dengan kajian histopatologi. Nilai LC50 sebanyak 9.00 dan 
3.87 mg/mL untuk masa olahan selama 6 dan 24 jam telah diperolehi bagi ekstrak 
daun E. guineensis dimana ia tidak menunjukkan sebarang kesan toksik terhadap 
Artemia salina, manakala mencit yang diberi ekstrak pada dos yang tinggi iaitu 
sebanyak 5,000 mg/kg berat badan melalui oral  pula, tidak menunjukkan sebarang 
kematian atau bukti kesan sampingan. Kajian pemeriksaan histology organ-organ 
yang penting juga tidak menunjukkan sebarang perbezaan diantara mencit yang 
dirawat ekstrak dengan mencit kawalan. Ini nyata mengesahi E. guineensi sebagai 
xx 
 
unsur bukan toksik. Pencirian kehadiran sebatian kimia aktif dalam ekstrak E. 
guineensis telah diperhatikan melalui kaedah analisis spektroskopi FTIR dan 
kromatografi gas–spektroskopi-jisim (GC-MS). Keputusan kajian FTIR ekstrak E. 
guineensis menunjukkan kehadiran kumpulan berfungsi yang mengesahkan aktiviti 
antimikrob dan antioksidaan manakala analisis GC-MS menunjukkan kehadiran 11 
komponen aktif. Empat daripada komponen ini didapati menyumbang kepada aktiviti 
antimikrob sementara 6 komponen pula bertanggung jawab terhadap aktiviti 
antioksidaan. Sebagai kesimpulan boleh dikatakan bahawa ekstrak daun E. 
guineensis telah menunjukkan aktiviti antikandida yang sangat baik bersama-sama 
dengan aktiviti antikanser dan antioksidaan berkesan tanpa menunjukkan kesan 
toksik. Maka, penggunaan daun kelapa sawit secara komersial daripada bahan 
buangan industri kelapa sawit untuk diubah sebagai produk farmaseutikal yang 
berguna boleh membawa pulangan yang lumayan kepada bidang industri 
farmaseutikal negara.   
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ANTIMICROBIAL, ANTICANCER AND ANTIOXIDANT ACTIVITIES OF 
METHANOLIC EXTRACT OF Elaeis guineensis Jacq. LEAVES. 
 
ABSTRACT 
 
Malaysia, being one of the economically industrious producers of oil palm around 
the world correspondingly, had recognized for its assiduous and phenomenal 
expansion of oil palm (Elaeis guineensis) plantings. Though the plantation had 
considerably contributed to the nation, the by-products yielded during replanting, 
harvesting and pruning became controvertible. There are several by-products of oil 
palm, explicitly oil palm fronds (OPF) had been contributing 70% to the overall oil 
palm industry waste in the country which reportedly produced around 30 million tons 
annually of oil palm biomass, including trunks, fronds, and empty fruit bunches. One 
of the significant problems in palm fruit processing is managing the wastes generated 
during the process. Hence, this study was executed to transmute oil palm industrial 
waste into remedial pharmaceutical products to which activities such as 
antimicrobial, anticancer, antioxidant and cytotoxicity were evaluated. The 
antimicrobial activity of the extract was completed using disc diffusion method and 
minimum inhibitory concentration (MIC) assay per broth macrodilution method. The 
extract was found to be potent towards the tested microorganism with the MIC 
reading between 6.25- 50.00 mg/mL. It was found that the extract works effectively 
against pathogenic yeast, C. albican, under the MIC value of 6.25 mg/mL and this 
result was again reinstated through time killing assay. Scanning Electron Microscopy 
(SEM) and Transmission Electron Microscopy (TEM) were conducted to observe the 
morphological metamorphosis between extract treated C. albicans and untreated 
control cells. The visual image results of SEM and TEM further testify the 
significant effects of the extract against the cell wall and the cytoplasmic contents of 
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C. albicans cells eventuating in the destruction of cells that are exposed to the 
concentration of 6.25 mg/mL E. guineensis extract throughout 36 hours. The 
anticancer activity of the extract was performed using cancerous MCF-7 cell lines 
and non-cancerous Vero cell lines through MTT method. The extract inhibits the 
cancerous cell proliferation at the concentration of (15.26 μg/mL) while the normal 
Vero cells were inhibit at (22.53 μg/mL). It was concluded that the extract was toxic 
towards the cancerous MCF-7 cell lines. Alongside antibacterial and anticancer 
activities, the antioxidant activities of E. guineensis leaf extract were determined 
using Diphenyl-1-picrylhydrazyl (DPPH) Scavenging Assay, Total Phenolic Content 
(TPC), Xanthine Oxidase Inhibitory (XOI) Assay, Nitric Oxide Inhibitory (NOI) 
Assay and Hydrogen Peroxide Scavenging Assay (HPSA). The extract exhibited 
scavenging activities of DPPH, XOI, NOI and HPSA methods with the IC50 values of 
814.00 μg/mL, 37.48 g/mL, 534.04 g/mL and 1052.02 respectively, while a total 
of 333.3 µg GAE/g of dry extract was achieved for total phenolics contents. The 
cytotoxicity activities of the extract were evaluated using brine shrimp assay 
(Artemia salina) and an oral acute toxicity using Swiss albino mice which were then 
followed by mice histopathalogical study. The values of LC50 obtained from brine 
shrimp assay were 9.00 and 3.87 mg/mL for 6 and 24 hours respectively which were 
interpreted as non toxic to A. salina whereas the mice administrated with the oral 
dose of 5000 mg/kg did not display any signs of adverse effects. The subsequent 
histophatological study revealed similar pathological patterns present in both E. 
guineensis treated and non-treated mice (control) vital organs which clearly state that 
E. guineensis is non-toxic. Identification of active ingredients present in E.guineensis 
was conducted using Fourier Transform Infrared (FTIR) Spectroscopy Analysis and 
Gas Chromatography-Mass Spectroscopy (GC-MS) Analysis. The FTIR exhibited 
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chemical functional groups supporting the antimicrobial and antioxidant properties of 
E. guineensis extract while the GC-MS analysis indicated 11 active compounds out 
of which 4 compounds were believed to be part of the contribution factor of 
antimicrobial activities while 7 were responsible for antioxidant activities. In 
adumbration, the leaf extract of E. guineensis had explicit good anticandidal activity, 
standing as a potential source of antioxidant and anticancer agent without 
significantly causing toxicity effects. Therefore the economic utilization of the leaf 
material from the oil palm industry waste can be converted into a beneficial 
medicinal value which will in return ameliorate the pharmaceutical industry of the 
nation.
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CHAPTER 1.0: INTRODUCTION 
 
Malaysia is one of the largest producers of oil palm (Elaeis guineensis Jacq.) in the 
world, stating 17.7 million barrels of crude oil in February 2012 (DOS, 2012). Total 
planted area of oil palm increased from 73, 000, reaching 3.87 million hectares in 
2004 and 5 million hectares in 2011 (Clark, 1996; MPOB, 2012). Oil palm fronds 
(OPF) contribute 70% to the overall oil palm industry waste in the country (Alper, 
1998), which reportedly produces about 30 million tons annually of oil palm 
biomass, including trunks, fronds, and empty fruit bunches (Joseph, 2010). One of 
the significant problems in palm fruit processing is managing the wastes generated 
during the process. In Malaysia, for example, 9.9 million tons of solid wastes 
consisting of oil palm empty fruit bunches, fiber, and fruit shells, and 10 million tons 
of palm oil mill effluent (POME) were generated every year. The country uses 
millions of hectare for plantations of oil palm, and large quantities of cellulosic and 
non-cellulosic raw materials were produced during harvesting (Joseph, 2010). The 
expansion of plantations in the country has generated large amounts of agro waste, 
creating problems in replanting operations and tremendous environmental concerns. 
When left on the plantation floor, these waste materials produce serious 
environmental problems (Afolayan and Meyer, 1997; Hernández et al., 2003). 
 Meanwhile, the discovery and the development of penicillin by Alexander 
Fleming had changed the entire direction to treating infectious diseases and saved the 
lives of millions of people (Berger, 1989). Antibiotics are probably the most 
successful family of drugs so far developed for improving human health.  Besides 
this fundamental application, antibiotics (antimicrobials at large) have also been used 
for preventing and treating animals and plants infections as well as for promoting 
growth in animal farming (McManus et al., 2002; Smith et al., 2002; Singer et al., 
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2003; Cabello, 2006). All these applications made antibiotics to be released in large 
amounts in natural ecosystems. Little is known on the overall effects of antibiotics on 
the population dynamics of the microbiosphere (Sarmah et al., 2006). However, the 
effect of antibiotics used for treating infections or for farming purposes in the 
selection of antibiotics–resistant microorganisms, which may impact human health 
has been studied in more detail (Witte, 1998; Ferber, 2003; Singer et al., 2003). As 
stated by the World Health Organization, the increasing emergence of antibiotic 
resistance in human pathogens is a special concern, not only for treating infectious 
disease, but also for other pathologies in which antibiotic prophylaxis is needed for 
avoiding associated infections. In this regard, the spread of antibiotic-
resistant bacteria means that commonplace medical procedures once previously taken 
for granted could be conceivably consigned to medical limbo. The repercussions are 
almost unimaginable (WHO, 2000). 
Bacterial resistance is a perfect example of natural selection. The widespread 
use or misuse of these drugs had killed off susceptible cells, leaving the rare resistant 
strains to survive and repopulate the ranks.  Many infectious disease specialists are 
predicting that the problem of antibiotic resistant will soon be acute in the coming 
years and the fatalities from once curable diseases will increase sharply. Finally, 
pharmaceutical companies responding to this threat and are beginning to search for 
new types of antibiotics. Most of the antibiotics derived from natural products, 
produced by microorganisms or plants to kill other microorganisms. Antibiotics work 
by interfering with bacterial activities without affecting the eukaryotic cells (Karp, 
2005). 
The rise in microbial drug resistance and opportunistic infections especially 
the ones affecting individuals on immunosuppressive chemotherapy and AIDS 
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patients had all together created a different scenario. The discovery of many 
antifungal started but went in vain due to toxicity, where else other infectious were 
yet to be found cure. These problems have triggered the search for new alternative 
substances from other sources such as plants (Cowan, 1999). Natural products in the 
form of pure compounds or as standardized plant extracts provide unlimited 
opportunities for the discovery of new drugs since plant contains unmatched 
availability of chemical diversity (Cos et al., 2006). According to WHO (2000), 
about three quarter of the world population depends on traditional remedies for their 
health care (Gilani and Atta-ur-Rahman, 2005). 
Therapies developed along the principles of Western medicine are often 
limited in efficacy, carry the risk of adverse effects, and are often too costly, 
especially for the developing world. Therefore, treating diseases with plant-derived 
compounds which are accessible and do not require laborious pharmaceutical 
synthesis seems highly attractive. Furthermore, in spite of the advances in 
conventional medicine in the last decades, professionals and the lay public of 
developed countries pay increasing attention to phytomedicine. Several recent 
surveys from Europe and the United States have demonstrated a sharp rise in the use 
of botanical drugs within a few years, and up to 65% of patients with liver disease 
take herbal preparations (Flora et al., 1996; Kessler et al., 2001; De Smet, 2002; 
Strader et al., 2002). Similar figures exist for Europe where the expenses for 
silymarin, an herbal preparation used to treat chronic liver diseases, reaches $180 
million in Germany alone (Pradhan and Girish, 2006). Many factors contribute to 
herbal medicine’s appeal. Supporters of herbal medicine claim that herbs may both 
treat and prevent diseases upon where these treatments are believed to be safe 
because they are “natural” and fit into the image of a gentle and, therefore, harmless 
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alternative to conventional medicine. More so, patients are often dissatisfied with the 
latter because of disappointing treatment success or unfavorable side effects. In 
addition, herbal products are often exempt from rigorous regulations, such as in the 
U.S., and prescriptions are usually not required for these inexpensive products 
(Stickel and Schuppan, 2007). 
E. guineensis is one of the plants that are central to the lives of traditional 
societies in West Africa. All parts of this plant are useful. The wood is used as 
frames for buildings, and the sap is fermented into palm wine. The oil from the fruit 
mesocarp and the seeds are used for cooking, and making soaps, creams, and other 
cosmetics.  The fresh sap is used as a laxative, and partially fermented palm wine is 
administered to nursing mothers to improve lactation. The fruit-husk is used in the 
preparation of soaps used to treat skin infections. A root decoction is used to treat 
headaches in Nigeria. The pulverized roots are added to drinks as a cure for 
gonorrhea, menorrhagia, and bronchitis (Muthu et al., 2006). The leaf extract and 
juice from young petioles are applied to fresh wounds. The fruit mesocarp oil and 
palm kernel oil are administered as a poison antidote and used externally with several 
other herbs as a lotion to treat skin diseases. Palm kernel oil is applied to convulsive 
children to regulate their body temperature. Oil palm is a folk remedy for cancer, 
headaches, and rheumatism, and is considered an aphrodisiac, a diuretic, and a 
liniment (Muthu et al., 2006).  
Since oil palm have been used in many ways to treat diseases caused many 
microbes, there is notably great potential for findings of a new pytochemical 
substances in the leaves of Elaies guineensis which could reduce the emergence of 
antibiotic resistance bacterial. In conjunction of these new findings, a large part of 
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the oil palm trees would also, not to go waste annually and instead, might benefit the 
country economically in the pharmaceutical sector.  
1.1 Objectives 
 
The current study was conducted with the following objectives: 
1) To obtain the optimum methanol extracts from E. guineensis leaves by means 
of maceration methods for antimicrobial, anticancer, antioxidant and 
cytotoxicity testings. 
2) To scientifically investigate the rationale behind traditional usage in 
searching for curative properties by conducting antimicrobial, anticancer and 
antioxidant activities testing on the methanol extracts of E. guineensis leaves. 
3) To further extract and isolate fractions or bioactive compound(s) of   
therapeutic potential from E. guineensis leaves using FTIR and GC-MS 
techniques.  
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CHAPTER 2.0: LITERATURE REVIEW 
 
2.1 Antimicrobial 
2.1.1 Antimicrobial Agents  
The rising of infections acting in conjunction with the global spread of drug-resistant 
bacterial pathogens had been a superlative denotation in executing new requisite 
approaches. The death toll cause by infectious diseases over the 20
th
 century had 
designated a scrutinous pattern; from 1900 to 1980, the toll dropped from 797 per 
100,000 people to 36 per 100,000 people, a reduction by a factor of more than 20 and 
a testament in part to the efficacy of antibiotics (NRC, 2006).  Even so, from 1980 to 
2000, the toll doubled, chiefly due to HIV and also with the spread of drug-resistant 
bacterial pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant enterococci, multiple-drug-resistant gram-negative bacteria, 
and multiple-drug-resistant tuberculosis (Cohen, 2000). The manifestation of 
infections coinciding with patients of serious illness or immuno-compromised 
relatively institutes an elevation in mortality rate that constrains inevitable 
necessitation for new techniques in treating pathogens which are resistant towards 
coeval antibiotics.  However, these present days sparked more imperative desolation 
due to untreatable pathogen infections, which had never been an issue since the pre-
antibiotic era (Cohen, 2000). 
Antibiotic resistance that develops in one or more patients insinuates a global 
promulgation threatening everyone’s health. Formerly, antibiotic resistance was 
incontrovertibly afflicted with the most ailing patients in the intensive- care wards; 
notwithstanding, currently it became a pervasive throughout the world. The pathogen 
strains, markedly bacteria, carries commonly clustered resistance genes which are 
now recognized as multiple-drug-resistant strains with the ability to spread resistance 
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together. The severity is increased along with the contribution from international 
travel frequency blended with the lack of standard knowledge on antibiotic usage, 
leading to expedite spread of resistance to every environment around the globe. 
Cognizance of antibiotic- resistance crisis generally pertains to predictable and 
severely loss of efficacy of current antimicrobial repository, yet considerable 
economic status had permitted the development of new antimicrobial agents and 
therapies to persevere (Nathan, 2004). 
 An antimicrobial agent exerts to kill or inhibit the growth of infectious 
bacteria by further hindering deterioration while antifungal agent combats against 
fungi in the same manner (McDonnell, 2007). These powerful substances namely 
known as antibiotics constitute an array of agents recognized as antibacterial, 
antifungal, antiprotozoal, antihelminthic and antiviral (Baron et al., 1994). In nature, 
bacteria and fungi obviate intruders (e.g, other microorganisms) by secreting 
compounds known as antibiotics (Greenwood and Whitley, 2003). The branch of 
knowledge colligating with antimicrobials was initiated by Pasteur and Joubert who 
ferreted out the aptitude of one type of bacteria in preventing the growth of another. 
It was later conceptualize that antibiotic produced by the antecedent was the cause of 
the other bacterium cessation. Like a shot, antibiotic became a prevailing term 
tributary to any drug that cures bacterial infection. Antimicrobial agents do not only 
pertain to naturally synthesized antibiotic compounds, but also to synthetically form 
compounds (Greenwood and Whitley, 2003). 
 Presently the disclosure of cardinal target (s) found on bacteria had embark a 
new strategy in understanding the metabolism and the sequencing genes of bacteria 
(Brazas and Hancock, 2005).  The principle of a good antimicrobial agent and drug 
discovery is anticipated upon the discernment of bacterial genomics and their related 
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technologies. However, the progress on establishing new antimicrobial agents based 
on genomic approaches is still under trial at the stage of late clinical development 
(Coates et al., 2002). 
2.1.2 Characteristics of antimicrobial Agent’s Activities in vitro 
2.1.2.1  Antimicrobial Activity is Measurable 
Adhering to accepted standards, the clinical microbiology laboratories had 
effectuated numerous susceptible tests encompassing disc diffusion, broth dilution 
and agar dilution methods that literally engage the measurement of minimal 
inhibitory concentration (MIC) of an antimicrobial agent. These tests are passable in 
thwarting bacterial replication at new sites efficaciously acting in conjunction with 
most clinical situations as well as boosting the competence of host’s defense 
mechanism into extirpating the bacterial invasion. The combination of antimicrobial 
assays with MICs provides trenchant information on the pharmacokinetics of the 
agent (s) allowing the eradication of bacteria to be predicted (NCCLS, 1999). 
 The lowest concentration of an antimicrobial agent required to inhibit the 
visible growth of microorganism is defined as MICs. MICs are employed to ascertain 
the range of accepted antibiotic concentrations with the implication of doubling 
dilution steps up and down from 1 mg/L as required. The inhibition of bacterial 
growth occurs after overnight incubation upon where the length of period enjoins 
contingently with the type of microorganism, say anaerobes, which call for longer 
incubation for growth (Andrew, 2001). This method begets results that can be either 
interpreted as semi-quantitative or qualitative (Andrew, 2001). 
 Apart from MIC tests, typical clinic or veterinary laboratories transact in vitro 
susceptibility testing by employing disc diffusion method. The method discharges 
measurable activity relatively to the size of the inhibition zone generated, 
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encompassing the embedded agent disc. The elucidation of these in vitro results 
relies comparatively solid upon the standards of United States recommended earlier 
by the National Committee for Clinical Laboratory Standards (NCCLS, 2003). The 
NCCLS is now known as Institute of Clinical Laboratory Standards (ICLS), British 
Society for  Antimicrobial Chemotherapy (BSAC) and the European Committee for 
Antimicrobial susceptibility testing (EUCAST), which exist as guidelines for 
antimicrobial susceptibility testing of conventional drugs (Ncube et al., 2008). 
 There are two modes referred to the action of an antimicrobial agent 
skirmishing bacteria that congruent well with the term bacteriostatic or bactericidal. 
Bacteriostatic prevents bacterial growth while bactericidal means killing them. 
Certain antimicrobials become lethal to bacteria at the concentration equal or higher 
than MIC while others generally possess bacteriostatic activity. Nonetheless, in 
reality, these agents act exceptionally. The “bactericidal” effect would not kill every 
microorganism implied chiefly to be existing in large colonies, within 18 to 24 hours 
of test and in such wise the “bacteriostatic” agents kill some bacteria within the 18 to 
24 hours after the test; often more than 90–99% of the inoculum, yet, not enough to 
be called “bactericidal.” On those grounds, the absolute indication on whether an 
antibacterial agent is bactericidal or bacteriostatic confides within the conditions of 
bacterial growth and density, duration of test and the reduction tendency in bacterial 
rates. Along these lines, the clinical definition falls vagarious. Generally, 
antibacterials are better described as potentially being both bactericidal and 
bacteriostatic (Pankey and Sabath, 2004). 
 At all events, in vivo resolve into an alternate option to stipulate a typical 
drug’s contingency of being bactericidal but in many instances were waived due to 
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technical and interpretive adverse circumstances (Lopes and Moreno, 1991; 
Amsterdam, 1996). 
 Killing curve stands as a collateral method in observing microbes responding 
to antimicrobials in vitro. The measurement of the killing effect betides reciprocally 
to the exposure of the microbes to a given concentration of drug and the population 
reduction is measured over time. The bactericidal effect can also be measured in the 
serum, commiserating the in vivo antimicrobial activity, often derivable from the 
subsisting serum components (MacGowan et al., 1997). 
 
 2.1.2.2 Antimicrobial Activity is Specific 
Microbes have one or more specific target components on their cells requisite in 
regulating physiological and replication activities. These targets are submissible in 
transit to the action of antimicrobial agents, explaining the classification of 
antimicrobials being based on their action mechanism. For example, β-
lactam drugs achieve their effect by inhibiting a group of bacterial membrane 
proteins called penicillin-binding proteins resolute for cell wall synthesis (Spratt, 
1980; Spratt and Cromie, 1988) while those with high molecular weights 
normatively proceed through multiple enzymatic functions. Hence, these proteins 
serve as docking targets for β-lactam drug activity. 
Come what way, the antimicrobial drugs efficacious  either through a direct 
event subsequent to the inhibition of the same cellular targets or an indirect one 
continuously appearing after a cascade of reaction exerting from a particular drug-
bacteria interaction (Yan and Gilbert, 2004).  
 The antimicrobial agents have variegated mechanisms in extirpating or 
ceasing the growth of microbial cells as illustrated in Figure 2.1; (i) Inhibition of cell 
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wall synthesis (e.g. penicillins); (ii) Inhibition of protein synthesis (e.g. 
tetracyclines); (iii) Alteration of cell membrane (e.g. polymyxins); (iv) inhibition of 
nucleic acid synthesis (e.g. quinolones); and (v) antimetabolite activity (e.g. 
sulfonamides) (Greenwood and Whitely, 2003). Multitudinous mechanisms ascribing 
antibiotic reaction, relate to obliterating the synthesis mechanisms of bacterial cell 
wall. It is sensible that most of living bacteria cells are assembled from cell 
membranes playing imperious role in regulating the movement of substances across 
the inner and the outer surroundings.  
 In no manner, the future is still on dubitancy on the adequacy of antimicrobial 
therapy. Bacteria are felicitously resisting antimicrobial agents to a greater extension. 
Hospitals emerge to aggregate concrete mutably bacteria eliciting drawbacks in case 
of susceptible patients. As of now, the discovery of drugs is the only tool to content 
against bacterial resistance. Yet, microorganisms are becoming resistant faster than 
the rate at which new drugs are being made available; thus, future research in 
antimicrobial therapy may focus on finding how to overcome resistance to 
antimicrobials, or how to treat infections with alternative means. 
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Figure 2.1: Ways on how antimicrobial agents target in ceasing the growth of 
microbial cells. 
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2.1.3 Evaluation of Antimicrobial Activity 
A successful management of bacterial infections co-exists with a good comparative 
integration analysis of antimicrobial agents that gives rise to an accurate 
determination of bacterial susceptibility towards antibiotic. Various microorganisms 
are allowed to react towards natural extracts and pure compounds while observation 
of their growth response is measured as the rate of antimicrobial activity. A number 
of techniques were adapted that generally grouped into two major classes including 
the disc diffusion and the broth dilution method. Since, these methods do not possess 
the same level of sensitivity or standards, the results naturally subjected in term to 
their respective methods.  
 
2.1.3.1 Agar-Diffusion Method 
A simple way was introduced to determine the susceptibility of a microorganism to 
an antimicrobial agent involving the usage of micro-seeded agar plate which also 
infuses the diffusion of the agent into the agar medium. A reservoir imbued with the 
agent is exposed directly on the seeded agar surface. A reservoir can be of filter discs 
or stainless steel cylinders placed on the surface or holes punched in the medium. 
The hole -punch is applicable for aqueous extracts due to the interference by 
particulate matter is much lesser that with other reservoir types. Again, only a speck 
of sample is required and the possibility to test up to six extracts per plate against a 
single microorganism is its unique way of being advantageous (Hadacek and Greger, 
2000). Non- polar samples or samples that find hard to diffuse into agar will not be 
appropriate to use hole-punch method.  
  The seeded system along with the disc is placed at lower temperature for 
several hours before incubation to provoke compound diffusion over the growth of 
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microbial. The substances start to diffuse from the disc into the agar taking after 
decrease in the concentration as a function of the square of the diffusion distance. 
The substances from the antimicrobial agent will travel to the line of demarcation 
upon where it exist more diluted and no longer have the aptitude to impound the 
microbial growth.  
The interaction between a specific antimicrobial agent and bacterial isolate 
will be revealing clear zones formations simply known as growth-inhibition zones 
surrounding the disc. The zones that manifest as clear areas are easily measurable 
with a ruler and the outcome of the diameter can be used to build an antibiogram 
(Atlas et al. 1995). A swift assessment of the antimicrobial activity for any water 
soluble compound is procured from the agar diffusion test that accommodates basic 
antimicrobial data concerning manufacturing and quality control assurance of 
finished product (Block, 1991; Ascenzi, 1996; Paulson, 1999). 
Samples of different types are incongruous to be compared in yielding the 
potentiality of a certain antimicrobial. This may be contributed by the differences in 
physical properties that comprise solubility, volatility and diffusion characteristics in 
agar (Cos et al., 2006). 
 
2.1.3.2 Dilution Method 
Broth dilution is a vulgar method appointed in resolving the minimal inhibitory 
concentration (MIC) of antimicrobial agents that clap together antibiotics and other 
substances that kill (bactericidal activity) or inhibit the growth (bacteriostatic 
activity) of bacteria. Broth dilution utilizes a suspension of microorganism growing 
in liquid medium reacting against geometrically increasing concentrations 
(commonly, a twofold dilution series) of the antimicrobial agent (Wiegand et al., 
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2008). The affiliated antimicrobial agent and its liquid medium are serial diluted, in 
consideration of the definite number of bacterial cells in an inoculum and time of 
incubation.  The final volume of the investigation will allocate the method as 
macrodilution (employing a total volume of 2 mL) or microdilution (achieving using 
microtiter plates using ≤ 500 mL per well). Succeeding incubation, the presence of 
turbidity or sediment betokens the growth of microorganisms. The turbidity is 
consummated by visual estimation or through optical density at 405 nm. Test 
samples that dissolve partially at any rate will contravene with turbidity reading, 
calling attention for the stipulation of negative or sterility control (Cos et al., 2006). 
The broth dilution herein, incorporates MIC that defines as the lowest concentration 
of the antimicrobial agent requirement to prevent the growth of microorganisms 
obligated to defined conditions (Wiegand et al., 2008). 
 
2.2  Candida 
The ordinary human system avouches Candida being in favour with flora found in 
skin, mouth, vagina and stool. Candida is thin walled, small yeast stretching from 4 
to 6 microns that reproduces by budding. Being the most common opportunistic 
mycoses pathogen and a colonizer, Candida is widely known to be existing in 
environment subsisting namely on leaves, flowers, water and soil. There are 154 
species known to be abiding within the genus Candida, italicizing six as the most 
frequently isolated from human infections. The Candida colonies that come in pasty, 
smooth, dry, wrinkled and dull appear cream to yellowish in colour, growing swiftly 
routing maturity within 3 days. The Candida is unicellular yeast and transpires 
alternatively to multicellular mold giving the chance to reproduce in such sexual or 
asexual manner by forming spores or budding. 
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 A certain number of Candida species turn up to be harmless commensally 
manifesting along the gastrointestinal and genitourinary tract. All the same time 
eliciting a range of painful medical conditions ranging from painful superﬁcial 
infections, such as vaginitis and in nay rather healthy women causing severe surface 
infections of the mouth and esophagus in human immunodeﬁciency virus (HIV) 
patients, and life threatening blood stream infections among vulnerable intensive care 
patients (especially those undergoing cancer chemotherapy or immunosuppressive 
therapy following organ or bone marrow transplant procedures) (Kao et al.,1999). 
Candidemia is a very common hospital acquired (Beck-Sagué and Jarvis, 1993; 
Edmond et al., 1999) infections with annual medical expenditure amounting to 
exceed $1 billion (Miller et al., 2001) not to mention the mortality rates caused per 
year, apparently being the major public health concern.  
 Even though, infections caused by other Candida species are elevating 
worldwide, still candidiasis continues to be preponderant, attributing these facts to 
Candida albicans. A staggering feature of C. albicans morphology is its ability to 
colonize in variety forms scoping from unicellular budding yeast (Figure 2.2a) to true 
hyphae with parallel-sided walls (Figure 2.2 b–d) (Odds, 1985; 1988; Merson-Davies 
and Odds, 1989; Gow, 1994; 1997; Berman and Sudbery, 2002; Gow, 2002). The 
fungus also displays numbers of growth forms that can be cumulatively referred to as 
pseudo-hyphae upon the elongation of daughter bud take place (Figure 2.2e) and, 
after septum formation, the daughter cell remains attached to the mother cell. Along 
these lines, filaments yielded by elongated cells with constrictions at the septa are 
formed (Figure 2.2 f–h). The buds elongation from pseudohyphae springs up in 
extreme 
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resembling superficial hyphae (Figure 2.2 c, g). Thus the pseudo-hyphae and hyphae 
collectively referred to the term filamentous.  
 The membrane of Candida contains large quantities of sterols, usually 
ergosterol. Apart from a few exceptions, the macroscopic and microscopic cultural 
characteristics of the different Candida species are similar. They can metabolize 
glucose under both aerobic and anaerobic conditions. Several studies have 
demonstrated that infection with Candida is associated with certain pathogenic 
variables. Adhesion of Candida to epithelial cell walls, an important step in initiation 
of infection, is promoted by certain fungal cell wall components such as mannose, 
C3d receptors, mannoprotein, and saccharins (Ghannoum et al., 1986; Kanbe et al., 
1991; Brassart et al., 1991). The degree of hydrophobicity (Hazen et al., 1991) and 
ability to bind to host ﬁbronectin (Klotz and Smith, 1991) has also been reported to 
be important in the initial stages of infection. Other factors implicated are germ tube 
formation, presence of mycelia, persistence within epithelial cells, endotoxins, 
induction of tumor necrosis factor, and proteinases. (Cutler et al., 1972; Saltarelli et 
al., 1975; Sobel et al., 1984; Kwon-Chung et al., 1985; Smith, 1985; Riipi and 
Carlson, 1990). Phenotypic switching which is the ability of certain strains of C. 
albicans to change between different morphologic phenotypes has also been 
implicated (Slutsky et al., 1985). 
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Figure 2.2: Yeast, hyphal and pseudohyphal morphologies. (a) Budding yeast cells 
(b) Hyphal germ tubes (e) Pseudohyphal buds in the conditions used, 25% of 
the cells are hyphal, examples of these are indicated by an arrow plus ‘Hy’. 
(c) Hyphae continue to display parallel-sided walls with no constrictions or 
branches. (d) Mature hyphal mycelia. (e) Pseudohyphae exhibit morphologies 
ranging from short pseudohyphae that are appear to be polarized yeast cells to 
(g) two long pseudohyphae that superﬁcially resemble hyphae. (h) Mature 
pseudohyphal mycelium. The images in (d) and (h) are of cells stained with 
Calcoﬂuor white, which stains chitin in the cell walls and septa. All scale bars 
represent 10 mm (Adapted: Sudbery et al., 2004). 
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2.2.1 Candida albicans 
Candida albicans are diploids acquainted with 6 to 8 chromosomes and primitively 
heterozygous since neither sexual nor parasexual cycle is known (Odds, 1988; 
Scherer and Magee, 1990; Pla et al., 1996). There is no known symptomatology 
associated to these fungi unless the compliance of propitious mode is assimilated 
with long-term antibiotic treatment and compromised local immune or barrier 
defences that initiate the conversion into becoming pathogenic. Those which are 
pathogenic have been classified into three broad categories: superficial, cutaneous, 
and systemic.  Superficial mycoses (systemic fungal infections) normally are 
confined to the keratinized layer of the skin and its appendages (Assaff and Weil, 
1996). The manifestation of cutaneous or subcutaneous mycoses of skin and 
cutaneous tissues prescriptively by way of traumatized area (wounded area); they 
conventionally remain localized but may spread throughout system with the aid of 
lymphatic. The systemic mycoses inveterately subjected to pulmonary inception, 
however may also affect most areas of the body (Chandler and Watts, 1996; Body, 
1996). Being the most pathogenic among the Candida species is the Candida 
albicans reputable as causative agent of oral mucosal layers, vaginal infections, skin 
and diaper rash to lethal disseminated candidiasis in those with compromised 
immune systems and those who had medical implantation devices such as artificial 
joint, a pacemaker and invasive bloodstream infections (O’Dwyer et al., 2007; 
Terrier et al., 2007; ten Cate, et al., 2009; Bhavan et al., 2010) elevating severity in 
millions of individuals globally.  
 Aberrant environmental conditions elicit the switch of one morphological to 
different morphology formations in C. albicans such as blastospores or 
blastoconidia, pseudohyphae, true hyphae and clamydospores. The unicellular yeast 
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form that divides by budding is termed a blastospore. Budding is associated with the 
growth of new cellular material from a small, selected site on the blastospore surface 
which observes the development of a daughter bud at the pole distal to the birth scar 
that eventually enters into a growing phase. Subsequently, the process of nuclear 
division eventuates in septum being formed in between the parent and daughter cell 
units contemporaciously known to form two blastspores. A hypha on the other hand, 
is a long microscopic tube consisting of one or more cells surrounded by a tubular 
cell wall that is divided by septa. The yeast – hyphal transition is denoted with the 
initial formation of germ tube. A blastospore produces new cellular material in the 
shape of a cylinder, known as the germ tube, which grows continuously by extending 
through the distal pole. Mitotic cell division takes place within the extending hypha 
and septa are formed at intervals along the hyphae without interrupting the rate of 
extension. Hyphae may arise either as branches of already existing hyphae or by 
germination of spores. A mycelium is the vegetative part of fungus and consists of 
the entire hyphae including all their branches (Bartegs et al., 1969; Molero et al., 
1998). This unique ability to switch between the yeast and the hyphal mode of 
growth has been implicated in its pathogenicity.  
 There were few influential factors that governs the hyphal phenotype in vitro; 
pH, temperature or compounds such as N-acetyl glucosamine, serum and proline 
(Molero et al., 1998). The laboratory has a unique environmental condition that 
favours the C. albicans to develop true hypha from blastospores as a response to 
serum. Additionally, factors such as high temperature, high ratio of CO2 and O2, 
neutral pH and poorly nourished media also contribute to the formation of hyphal 
growth. Acidic pH, low temperature, air and enriched media nonetheless, trigger the 
growth of blastospore (Mattia et al., 1982; Molero et al., 1998; Li et al., 2007). 
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The interaction between the host and the C. albicans encounter in such that 
the host apprehends the general survivance, fitness and persistence throughout the 
invasion of the virulent yeast that associate specific factors such as adhesion, 
invasion, cell damage and induction or evasion of host responses (Calderone and 
Braun, 1991; Naglik et al., 2003; Zhu and Filler, 2010). In retaliation, the host 
counterfires by concatenating mechanical barriers that resist fungal penetration such 
as epithelial surfaces, soluble antimicrobial factors, and innate and adaptive cellular 
immune mechanisms. This promulgates that a frail alterations of the physiology of 
host system may transform the harmless commensal yeast into a treacherous 
pathogen apt in rendering feeble illness emphasizing the importance of host defence 
system in maintaining C. albicans in the commensal state.  
 
2.2.2 Treatment for Candidiasis 
Topical antifungal therapy is the recommended ﬁrst line treatment for uncomplicated 
oral candidiasis and where systemic treatment is needed topical therapy should 
continue as this reduces the dose and duration of systemic treatment required 
(Epstein and Polsky, 1998). The systemic adverse effects and drug interactions that 
occur with the systemic agents do not occur with topical agents (Epstein et al., 1984).  
Treatment in the early part of the 20th century was with gentian violet, an aniline 
dye, but because of resistance developing and side effects, such as staining of the 
oral mucosa, it was replaced by a polyene antibiotic, nystatin, discovered in 1951 and 
amphotericin B, discovered in 1956. They act by binding to sterols in the cell 
membrane of fungi, and, altering cell membrane permeability (Bennett, 1990; Gupta 
et al., 1994).  Nystatin and amphotericin are not absorbed from the gastrointestinal 
tract and are used by local application in the mouth.  
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Miconazole, an imidazole, can be used as a local application in the mouth but 
its use in this way is limited because of potential side effects such as vomiting and 
diarrhoea. Other drugs belonging to this class are clotrimazole and ketoconazole. 
Nystatin is the most widely used topical agent for the treatment of oral candidiasis 
(Guida, 1988; Epstein, 1990).  It is available as an oral rinse, pastille, and 
suspension. It should be used as a rinse four times a day for two weeks. It can cause 
nausea, vomiting, and diarrhoea. The oral rinse contains sucrose and is useful in 
edentulous patients and those with xerostomia such as patients receiving 
radiotherapy and those with HIV infection (Epstein, 1993).  
Clotrimazole troche can be an alternative for those patients who ﬁnd nystatin 
suspensions unpalatable. Systemic antifungal therapy in oral candidiasis is 
appropriate in patients intolerant of or refractory to topical treatment and those at 
high risk of developing systemic infections (Epstein and Polsky, 1998). Both nystatin 
oral rinses and clotrimazole troches have high sucrose content and if tooth decay is a 
concern or the oral candidiasis is complicated by diabetes, steroid use or an 
immunocompromised state, triazoles which include ﬂuconazole or itraconazole once 
per day has been found to be effective in these cases (Blatchford, 1990). 
Ketoconazole is also as effective as ﬂuconazole and itraconazole but its use in elderly 
patients is not recommended due to drug interactions and side effects, which include 
hepatotoxicity. 
Fluconazole is a potent and selective inhibitor of fungal enzymes involved in 
the synthesis of ergosterol, an important constituent of the plasma cell membrane. It 
therefore disrupts cell wall formation leading to leakage of cellular contents 
eventuating in and cell death. It is well absorbed by the gastrointestinal tract and the 
plasma levels are found to be over 90% of the levels achieved with intravenous 
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administration similarly achieved for the levels in saliva and sputum are also similar 
to that in the plasma. It is preferred, as it does not have the same hepatotoxicity as the 
imidazoles. It is now listed in the dental practitioners’ formulary as well as the 
British National Formulary, the utilization spread between the dental and medical 
practice, yet there were no records with resistance problems. Itraconazole has a wider 
spectrum of activity than ﬂuconazole and is therefore valuable in salvage treatment 
patients with immunocompromised patients with ﬂuconazole resistant candidiasis. 
Increasing resistance to antifungals has become increasingly common since the 
introduction of ﬂuconazole especially in patients with advanced HIV disease, and 
recurrent and long term treatment (Heinic et al., 1993; Rex et al., 1995). 
Angular cheilitis is treated with antifungal steroid creams and ointments and 
any concurrent intraoral lesion is also treated at the same time and dietary 
deﬁciencies will be excluded and treated if found. Failure to respond to therapy 
especially in chronic atrophic candidiasis is usually due to non-compliance with 
treatment. Prophylaxis with antifungal agents reduces the incidence of oral 
candidiasis in patients with cancer undergoing treatment (Clarkson et al., 2000) and 
ﬂuconazole has been found to be more effective than topical polyenes (Lumbreras et 
al., 1996). Prophylaxis on either a daily or weekly basis with antifungals reduces the 
incidence of oral candidiasis in patients with HIV with the reductions being most 
marked in those with low CD4 counts and recurrent oral candidiasis (Powderly et al., 
1995; MacPhail et al., 1996; Schuman et al., 1997; Smith et al., 1999). The use of a 
chlorhexidine rinse only in bone marrow transplant patients as prophylaxis was 
found to be very effective (Ferretti et al., 1987). 
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2.3 Free Radicals and Antioxidants 
2.3.1 Free Radicals 
Stable atoms are predicated for being in ground state to which the word ‘ground’ 
connotes every electron in the outermost shell of an atom being complimentary with 
electron that spins in the opposite direction. When any atom (e.g. oxygen, nitrogen) 
procures with the least presence of one unpaired electron in the outermost shell 
collaterally existing independently, it is then accredited with the term free radical 
(Karlsson, 1997). A free radical eventuates, in which time a covalent bond 
disintegrates between entities resulting in unpaired electron in each newly formed 
atom (Karlsson, 1997). The formation of unpaired electron (s) is highly reactive as 
free radicals. Radicals are capable of existing as reactive oxygen species (ROS) or 
reactive nitrogen species (RNS). 
  Free radicals are formed within the human system either as an intercessor 
during indispensable biological processes that concerns neurotransmission and 
inflammatory reactions or simply as a byproduct that had no corresponding value in 
an actual process. In many instances, the aerobic reactions execute free radicals by 
reducing a minor part of the oxygen (approximately 1-3 %) during the oxidative 
phosphorylation (Madger, 2006).  
Come what way, there are also other external factors that coerced the 
accumulation of free radicals such as air pollution, ozone, nitrous oxide, cigarette 
smoke through active o passive, drugs, pesticides, contaminated or rancid foods, 
unsaturated fats and exposure to ionizing radiation example ultraviolet light, X-rays 
and cosmic (Greenly, 2004). The radicals will in turn oxidize other stable compounds 
transforming into free radicals themselves. These partly reduced forms of oxygen in 
unison are delineated as ROS and similarly RNS when nitrogen is involved. The 
